4-(4-Bromophenoxy)-7-methoxy-2,3-diphenylquinoline | 828300-19-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 4-(4-Bromophenoxy)-7-methoxy-2,3-diphenylquinoline
• CAS: 828300-19-2
• 化学式: C₂₈H₂₀BrNO₂
• 分子量: 482.376
• InChiKey: DBIHIRHFIGNLBA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.7
• 重原子数：
  32
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.04
• 拓扑面积：
  31.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-(4-Bromophenoxy)-7-methoxy-2,3-diphenylquinoline 在 palladium diacetate 、 三溴化硼 、 三乙胺 、 三苯基膦 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 生成 ethyl (E)-3-[4-(7-hydroxy-2,3-diphenylquinolin-4-yl)oxyphenyl]prop-2-enoate
  参考文献：
  名称：

  Discovery of Novel Quinoline-Based Estrogen Receptor Ligands Using Peptide Interaction Profiling

  摘要：

  Traditional approaches to discovery of selective estrogen receptor modulators (SERMs) have relied on ER binding and cell-based estrogen response element-driven assays to identify compounds that are osteoprotective but nonproliferative in breast and uterine tissues. To discover new classes of potential SERMs, we have employed a cell-free microsphere-based binding assay to rapidly characterize ER alpha interactions with conformation-sensing cofactor or phage display peptides. Peptide profiles of constrained triarenes were compared to known proliferative and nonproliferative ER ligands to discover potent quinoline-based ligands with minimal Ishikawa cell stimulation.

  DOI：

  10.1021/jm040154f
• 作为产物：
  描述：

  4-羟基-7-甲氧基-3-苯基喹啉-2(1H)-酮 在 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride 、 sodium hydroxide 、 potassium carbonate 、 三氯氧磷 作用下， 以 四氢呋喃 、 正己烷 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 4-(4-Bromophenoxy)-7-methoxy-2,3-diphenylquinoline
  参考文献：
  名称：

  Discovery of Novel Quinoline-Based Estrogen Receptor Ligands Using Peptide Interaction Profiling

  摘要：

  Traditional approaches to discovery of selective estrogen receptor modulators (SERMs) have relied on ER binding and cell-based estrogen response element-driven assays to identify compounds that are osteoprotective but nonproliferative in breast and uterine tissues. To discover new classes of potential SERMs, we have employed a cell-free microsphere-based binding assay to rapidly characterize ER alpha interactions with conformation-sensing cofactor or phage display peptides. Peptide profiles of constrained triarenes were compared to known proliferative and nonproliferative ER ligands to discover potent quinoline-based ligands with minimal Ishikawa cell stimulation.

  DOI：

  10.1021/jm040154f

文献信息

• Discovery of Novel Quinoline-Based Estrogen Receptor Ligands Using Peptide Interaction Profiling
  作者：William J. Hoekstra、Hari S. Patel、Xi Liang、Jean-Baptiste E. Blanc、Dennis O. Heyer、Timothy M. Willson、Marie A. Iannone、Sue H. Kadwell、Lisa A. Miller、Kenneth H. Pearce、Catherine A. Simmons、Jean Shearin

  DOI：10.1021/jm040154f

  日期：2005.3.1

  Traditional approaches to discovery of selective estrogen receptor modulators (SERMs) have relied on ER binding and cell-based estrogen response element-driven assays to identify compounds that are osteoprotective but nonproliferative in breast and uterine tissues. To discover new classes of potential SERMs, we have employed a cell-free microsphere-based binding assay to rapidly characterize ER alpha interactions with conformation-sensing cofactor or phage display peptides. Peptide profiles of constrained triarenes were compared to known proliferative and nonproliferative ER ligands to discover potent quinoline-based ligands with minimal Ishikawa cell stimulation.